These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8099696)

  • 1. Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator.
    Anderson GP
    Life Sci; 1993; 52(26):2145-60. PubMed ID: 8099696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of formoterol: an innovative bronchodilator.
    Anderson GP
    Agents Actions Suppl; 1991; 34():97-115. PubMed ID: 1686531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
    Anderson GP
    Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
    Lindén A; Rabe KF; Löfdahl CG
    Lung; 1996; 174(1):1-22. PubMed ID: 8746998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are long-acting beta-adrenoceptor agonists long-acting?
    Anderson GP; Lindén A; Rabe KF
    Eur Respir J; 1994 Mar; 7(3):569-78. PubMed ID: 7912202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P; Lötvall J; Lindén A
    Lung; 1996; 174(3):159-70. PubMed ID: 8830192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
    Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
    Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting beta 2-agonists.
    Tattersfield AE
    Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of formoterol, a long-acting beta 2-adrenoceptor agonist, on mucociliary activity.
    Lindberg S; Khan R; Runer T
    Eur J Pharmacol; 1995 Oct; 285(3):275-80. PubMed ID: 8575514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of long-acting beta-receptor agonists.
    Tattersfield AE
    Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction.
    Brusasco V; Crimi E; Gherson G; Nardelli R; Oldani V; Francucci B; Della Cioppa G; Senn S; Fabbri LM
    Pulm Pharmacol Ther; 2002; 15(4):399-406. PubMed ID: 12220946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
    Nials AT; Ball DI; Butchers PR; Coleman RA; Humbles AA; Johnson M; Vardey CJ
    Eur J Pharmacol; 1994 Jan; 251(2-3):127-35. PubMed ID: 8149969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.
    Bergendal A; Lindén A; Skoogh BE; Gerspacher M; Anderson GP; Löfdahl CG
    Br J Pharmacol; 1996 Mar; 117(6):1009-15. PubMed ID: 8882590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-allergic activity of formoterol, a new beta-adrenoceptor stimulant, and salbutamol in human leukocytes and human lung tissue.
    Mita H; Shida T
    Allergy; 1983 Nov; 38(8):547-52. PubMed ID: 6197899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jan; 51(1):54-8. PubMed ID: 8658370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
    Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
    Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.
    Nicholls DJ; Jordan S; Cadogan E; Lawson M; Austin RP; Paine SW; Gardiner P; Bonnert R; Connolly S; Young A
    Pulm Pharmacol Ther; 2012 Aug; 25(4):293-302. PubMed ID: 22659538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol delivered by Turbuhaler: in pediatric asthma.
    Cheer SM; Warner GT; Easthope SE
    Paediatr Drugs; 2003; 5(1):63-8; discussion 69. PubMed ID: 12513109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus.
    Naline E; Zhang Y; Qian Y; Mairon N; Anderson GP; Grandordy B; Advenier C
    Eur Respir J; 1994 May; 7(5):914-20. PubMed ID: 7914176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A; Lipworth BJ
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.